Lab Automation Market Report 2026

The lab automation market size has grown strongly in recent years. It will grow from $8.03 billion in 2025 to $8.83 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to rising complexity of laboratory research, increasing need for faster testing processes, growing emphasis on precision and reproducibility, expansion of pharmaceutical and biotech research, early adoption of mechanical lab assistance.

The lab automation market size is expected to see strong growth in the next few years. It will grow to $12.2 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to rising demand for automated diagnostic systems, increasing laboratory modernization initiatives, growing need for high throughput testing, expanding clinical and genomic research activities, strengthening investment in advanced laboratory infrastructure. Major trends in the forecast period include rising shift toward reducing manual laboratory workloads, growing focus on improving testing efficiency and throughput, increasing adoption of automated diagnostic systems, expansion of automated workflows across research environments, strengthening emphasis on accuracy consistency and reliability in labs.

The rising demand for personalized medicine is expected to propel the growth of the lab automation market going forward. Personalized medicine, also known as precision medicine, refers to a medical approach that tailors healthcare decisions, practices, interventions, and treatments to individual patients. The demand for personalized medicine is on the rise due to several factors, including advancements in genomics and molecular diagnostics, increased awareness and education, a growing burden of chronic diseases, and its cost-effectiveness. Lab automation improves the efficiency, accuracy, and scalability of laboratory procedures, allowing healthcare professionals and researchers to develop personalized medicine approaches that improve patient outcomes and optimize treatment efficacy. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based advocacy organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, a rise from just six approvals in 2022. Thus, rising demand for personalized medicine is driving the growth of the lab automation market.

Major companies operating in the lab automation market are developing innovative solutions such as lab automation systems for microbiology laboratories, to help optimize lab space and streamline work flow. Lab automation systems for microbiology laboratories are advanced technological solutions designed to streamline and enhance the processing, analysis, and management of microbiological samples and data. For instance, in January 2023, Becton, Dickinson, and Company, a US-based medical technology company, launched the new third-generation BD Kiestra Total Lab Automation System for microbiology laboratories. The system is modular and capable of supporting and matching the requirements of laboratories, thereby improving laboratory operations, increasing budgetary efficiencies, and advancing laboratory outcomes. It is a sophisticated, completely automated robotic system that streamlines and improves microbiology laboratory procedures such as sample processing, digital imaging, incubation, and result analysis. Furthermore, several features such as automated microbiology processes, modular and scalable design, the BD Synapys microbiology informatics solution, and high throughput processing, will transform clinical bacteriological testing, improve laboratory outcomes, and meet the changing needs of modern microbiology laboratories.

In March 2024, Bruker Corporation, a US-based manufacturer of scientific instruments, acquired Chemspeed Technologies AG for an undisclosed amount. Through this acquisition, Bruker aims to enhance productivity in research and development (R&D) and quality control (QC) departments by offering modular automation solutions that can transform R&D productivity in various industries such as pharmaceuticals, biotech, chemicals, materials, cosmetics, and food. Chemspeed Technologies AG is a Switzerland-based lab automation company that provides high-throughput and high-output research and development and quality control workflow solutions.

Major companies operating in the lab automation market report are Thermo Fisher Scientific, Becton Dickinson And Company (BD), Agilent Technologies Inc., PerkinElmer LLC, Beckman Coulter Inc., Biomek Inc., Bio-Rad Laboratories, QIAGEN N.V., Tecan Group, Brooks Life Sciences, Hamilton Company, Promega Corporation, Opentrons Labworks Inc, Analytik Jena AG, Gilson Inc., Eppendorf Corporate, Hudson Robotics, Beckman Coulter Life Sciences, Zymo Research Corp., Perceptive Instruments Ltd., Synthace Ltd., Festo Corp., Roche Diagnostics, Peak Analysis & Automation (PAA)

North America was the largest region in the lab automation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lab automation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lab automation market includes revenues earned by entities by providing services such as workflow analysis and optimization, system integration, custom software development, instrument maintenance and support, and training. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.